1. Association between structural and functional treatment outcomes in neovascular age‐related macular degeneration. Issue 2 (29th August 2022) Authors: Haji, Hauraz; Gianniou, Christina; Brynskov, Troels; Sørensen, Torben L.; Olsen, Rasmus; Krogh Nielsen, Marie Journal: Acta ophthalmologica Issue: Volume 101:Issue 2(2023) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Driving vision in patients with neovascular AMD in anti‐VEGF treatment. Issue 8 (5th March 2021) Authors: Ferløv Baselius, Nanna Jo; Brynskov, Troels; Falk, Mads Krüger; Sørensen, Torben Lykke; Subhi, Yousif Journal: Acta ophthalmologica Issue: Volume 99:Issue 8(2021) Page Start: e1360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes. Issue 1 (30th July 2016) Authors: Laugesen, Caroline Schmidt; Ostri, Christoffer; Brynskov, Troels; Lund‐Andersen, Henrik; Larsen, Michael; Vorum, Henrik; Sørensen, Torben L. Journal: Acta ophthalmologica Issue: Volume 95:Issue 1(2017) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Intravitreal ranibizumab for diabetic macular oedema: 1‐year experiences in a clinical setting. (31st December 2012) Authors: Brynskov, Troels; Laugesen, Caroline Schmidt; Sørensen, Torben Lykke Journal: Acta ophthalmologica Issue: Volume 91:Number 3(2013) Page Start: e243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Intravitreal ranibizumab for diabetic macular oedema: 1‐year experiences in a clinical setting. (31st December 2012) Authors: Brynskov, Troels; Laugesen, Caroline Schmidt; Sørensen, Torben Lykke Journal: Acta ophthalmologica Issue: Volume 91:Number 3(2013) Page Start: e243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study. Issue 12 (December 2017) Authors: Freiberg, Florentina J.; Brynskov, Troels; Munk, Marion R.; Sørensen, Torben L.; Wolf, Sebastian; Wirth, Magdalena A.; Becker, Matthias; Michels, Stephan Journal: Retina Issue: Volume 37:Issue 12(2017:Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Real‐world 10‐year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age‐related macular degeneration. Issue 2 (8th July 2019) Authors: Brynskov, Troels; Munch, Inger Christine; Larsen, Tobias Malte; Erngaard, Liv; Sørensen, Torben Lykke Journal: Acta ophthalmologica Issue: Volume 98:Issue 2(2020) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Similar real‐world two‐year visual acuity gains in treatment‐naive patients with diabetic macular oedema treated with a loading dose of three initial monthly injections versus less intensive regimens of intravitreal anti‐vascular endothelial growth factor. Issue 7 (6th May 2021) Authors: Lindboe, Johanne Bjerre; Schmidt Laugesen, Caroline; Sørensen, Torben Lykke; Brynskov, Troels Journal: Acta ophthalmologica Issue: Volume 99:Issue 7(2021) Page Start: e1248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Thickening of inner retinal layers in the parafovea after bariatric surgery in patients with type 2 diabetes. (26th May 2016) Authors: Brynskov, Troels; Laugesen, Caroline S.; Floyd, Andrea K.; Sørensen, Torben L. Journal: Acta ophthalmologica Issue: Volume 94:Number 7(2016) Page Start: 668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗